Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes.

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Abstract Text:

Richard A Fenton,James G Dobson,Richard A Fenton,James G Dobson,

In the heart beta1-adrenergic (beta1R) and adenosine A1 (A1R) and A2A (A2AR) receptors modulate contractile and metabolic function. The interaction between these receptors was investigated at the level of G-protein cycling by determining the effect of receptor agonists on the binding of GTP to G-proteins and displacement of G alpha-subunit-bound GDP by GTP. Crude membranes from rat heart or brain were stimulated by agonists for beta1R (isoproterenol; ISO), A1R (chlorocyclopentyladenosine, CCPA) and A2AR (CGS-21680; CGS). GTP binding to membranes was increased by ISO (17%), CCPA (6%) and CGS (12%). Binding values observed with incubation using ISO and CCPA together were significantly less than values obtained by the incubation of individual agents alone. With ISO, GTP binding to G alpha(s) subunits as determined by immunoprecipitation was increased 79% in heart and 87% in brain. These increases were attenuated by CCPA, an effect that was inhibited by CGS. GDP release by membranes was increased 6.9% and 4.6% by ISO and CCPA, respectively. After co-incubation of these agonists, release was increased less than determined by the addition of the individual agent responses. CGS inhibited the reduced release caused by of CCPA. Adenylyl cyclase activity stimulated by ISO was attenuated 33% by CCPA, an effect inhibited by CGS. Together, these results indicate that A1R exert an antiadrenergic action at the level of beta1R stimulated G(s)-protein cycling and that A2AR reduce this action.

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Publishing Authors By Initials

RA Fenton,JG Dobson,RA Fenton,JG Dobson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Journal Published:

PUBLICATION TYPE: Research Support, N.I.H., Extr

Journal: Journal of cellular physiology

VOLUME: 213

Page Numbers: 785-92

Journal Abbreviation: J. Cell. Physiol.

ISSN: 1097-4652

DAY: 2

MONTH: Dec

YEAR: 2007

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 50222

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes.

AFFILIATION: Department of Physiology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA. Richard.Fenton@umassmed.edu

Country: United States

AGENCY: United States NHLBI

GRANT: HL-66045

ACRONYM: HL

MEDLINETA: J Cell Physiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes Related Publications

• A lifestyle view of life-history evolution.
• Achievement of Energy Focus for Distance-of-Flight Mass Spectrometry with Constant Momentum Acceleration and an Ion Mirror.
• Adenosine A1 and A2A receptor effects on G-protein cycling in beta-adrenergic stimulated ventricular membranes.
• Agency urges researchers to make more use of yellow card data.
• An experimental investigation of the cognitive vulnerability to depression.
• An overview of faecal incontinence in children.
• Apolipoprotein E-derived antimicrobial peptide analogues with altered membrane affinity and increased potency and breadth of activity.
• CONVERGENCE.
• Dexamethasone and ondansetron incompatibility in polypropylene syringes.
• Early pituitary follicle stimulating hormone response to gonadotrophin releasing hormone in ewes.
• Economic cost of difficult calvings in the United Kingdom dairy herd.
• Effects of chronic treatment with a GnRH agonist on oestrous behaviour and on the secretion of LH and progesterone in the ewe.
• England and Wales are among European countries at highest risk of measles epidemic.
• HEPATIC CUTANEOUS PORPHYRIA. RESPONSE OF A PATIENT TO TREATMENT WITH ADENOSINE-5-MONOPHOSPHATE.
• Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.
• Human papillomavirus vaccines: who should get them and why?
• Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations.
• Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent.
• Nocturnal enuresis in children.
• Perceptions of Saskatchewan community pharmacists regarding a prior-authorization program.
• Preconditioning and postconditioning: innate cardioprotection from ischemia-reperfusion injury.
• Projected impacts of climate and land-use change on the global diversity of birds.
• Rose revisited: a "middle road" prevention strategy to reduce noncommunicable chronic disease risk.
• Study shows effect on life expectancy of greater spending on treatment.
• Teller Acuity Card norms with and without use of a testing stage.
• Training the trainers.
• Unnecessary C-sections.
• Variation in number of women being recalled after breast cancer screening needs to be looked into.
• Weighted multimorbidity indexes predicted mortality, health service use, and health-related quality of life in older women.
• gamma-amino butyric acid control of arginine vasopressin release from the ewe hypothalamus in vitro: sensitivity to oestradiol.